Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
|
| Revenues: | ||||
| Total Revenues | $ 557,089 | $ 675,831 | $ 1,386,165 | $ 2,415,941 |
| Cost of Sales: | ||||
| Product Cost of Sales | (476,453) | (323,527) | (1,076,779) | (872,847) |
| Gross Income | 80,636 | 352,304 | 309,386 | 1,543,094 |
| Administrative Expenses | 1,650,226 | 819,565 | 4,112,444 | 2,440,023 |
| Administrative Expenses - Related Party | 56,425 | 75,342 | ||
| Sales and Marketing Expenses | 381,994 | 342,763 | 1,292,844 | 1,254,308 |
| Sales and Marketing Expenses - Related Party | (17,353) | 34,328 | 41,418 | 128,108 |
| Research and Development Expenses | 160,867 | 290,447 | 805,619 | 929,730 |
| Research and Development Expenses - Related Party | 54,342 | 22,994 | ||
| Litigation Settlement Expenses | 930,000 | 930,000 | ||
| Amortization of Non-Current Assets | 42,777 | 42,777 | 128,331 | 128,331 |
| Loss from Operations | (3,124,300) | (1,177,576) | (7,130,954) | (3,360,400) |
| Other (Income)/Expenses | ||||
| Foreign Currency Transaction (Gain)/Loss | (634) | 3,195 | 5,271 | (6,172) |
| Other Income | (4,172) | (4,172) | ||
| Interest and Dividend Income | (35,545) | (3,127) | (120,659) | (9,296) |
| Total Other Income | (40,351) | 68 | (119,560) | (15,468) |
| Loss Before Income Taxes | (3,083,949) | (1,177,644) | (7,011,394) | (3,344,932) |
| Income Tax Benefit | ||||
| Net Loss Attributable to Common Shareholders | (3,083,949) | (1,177,644) | (7,011,394) | (3,344,932) |
| Other Comprehensive Income/(Loss) | ||||
| Net Unrealized Gain/(Loss) on Marketable Securities | 6,900 | (1,009) | (5,543) | |
| Total Other Comprehensive Income/(Loss) | 6,900 | (1,009) | (5,543) | |
| Comprehensive Loss | $ (3,077,049) | $ (1,178,653) | $ (7,016,937) | $ (3,344,932) |
| Basic and Diluted loss per common share | $ (0.26) | $ (1.04) | $ (0.65) | $ (3.2) |
| Weighted average basic and diluted common shares outstanding | 11,779,584 | 1,111,510 | 10,805,151 | 1,033,606 |
| Product Revenue [Member] | ||||
| Revenues: | ||||
| Total Revenues | $ 557,089 | $ 638,331 | $ 1,386,165 | $ 2,378,441 |
| License And Service Revenue [Member] | ||||
| Revenues: | ||||
| Total Revenues | $ 37,500 | $ 37,500 | ||
| X | ||||||||||
- Definition Administrative Expenses ? Related Party. No definition available.
|
| X | ||||||||||
- Definition Research and Development Expenses - Related Party. No definition available.
|
| X | ||||||||||
- Definition Sales and Marketing Expenses - Related Party. No definition available.
|
| X | ||||||||||
- Definition The expense charged against earnings during the period to allocate the capitalized costs of regulatory assets over the periods expected to benefit from such costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities and unrealized holding gain (loss) related to transfers of securities into the available-for-sale classification and out of the held-to-maturity classification. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before tax and reclassification adjustments of unrealized holding gain (loss) on available-for-sale securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|